Drug Overview: Cylert
Cylert was a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in the US for 30 years before being removed from the market following reports of liver failure. Cylert was manufactured by Abbott Laboratories, but generic forms of the same drug, pemoline, were marketed by other manufacturers. The Cylert claim was that it helped ADHD suffers relax and concentrate better by increasing levels of norepinephrine in the body. Norepinephrine is a naturally occurring chemical that causes nervous impulses to travel more quickly in the central nervous system.
Suffered harm from Cylert? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.
The FDA (Federal Drug Administration) approved the drug in 1975, but required a black box warning, the most serious warning available, for the risk of liver damage in 1999. The drug was still widely prescribed, often to children, and even liver function monitoring failed to prevent or predict liver failure in some patients.
Though the FDA ordered an end to the manufacture of these products in October 2005, the products that had already been manufactured were offered for sale. Public Citizen estimates that 10,000 prescriptions were written for pemoline products by doctors after the manufacturers agreed to stop making it.
Check out the following articles for more information about Cylert, filing a Cylert lawsuit and finding Cylert attorney.
Suffered harm from Cylert? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights. |